Medically another name for aricept 30 mg on Feb 1, The recommended starting dosage of Aricept is 5 mg administered once per day in the evening, just prior to retiring.
A dose of 10 mg should aricept be administered until patients have been on a daily dose of 5 mg for 4 to 6 weeks. A dose of 23 mg per day should not be administered until patients have been on a another name for dose of 10 mg for at least 3 months.
Aricept should be taken in the evening, just prior to retiring. Aricept can be taken with or without food. Aricept is supplied as film-coated, round tablets containing 5 mg, 10 mg, or 23 mg of donepezil hydrochloride.
Aricept ODT is supplied as round tablets containing either 5 another name for aricept 30 mg or 10 mg of donepezil hydrochloride. Aricept is contraindicated in patients with known hypersensitivity to donepezil hydrochloride or to piperidine derivatives.
Aricept, as a cholinesterase inhibitor, is likely to exaggerate succinylcholine-type muscle relaxation another name anesthesia. Because of their pharmacological action, cholinesterase inhibitors may have vagotonic effects another name for aricept 30 mg the sinoatrial and atrioventricular nodes. This effect may manifest as bradycardia or heart block in patients both with and without known underlying cardiac conduction abnormalities.
Syncopal episodes have been reported in association with the use of Aricept. Aricept, as a predictable consequence of its pharmacological properties, has been shown to produce diarrhea, nausea, and vomiting.
The percent of patients who discontinued treatment due to vomiting see more the 23 mg group was markedly higher than in the 10 mg group 2. Through their primary action, cholinesterase inhibitors may be expected to increase gastric acid secretion due to increased cholinergic activity. Therefore, patients should another name another name for aricept 30 mg aricept 30 mg monitored closely for symptoms of active or occult gastrointestinal bleeding, especially those at increased risk for developing ulcers, e.
Weight loss was reported as an adverse reaction in 4. Compared to their baseline weights, source. Although not observed in clinical trials of Aricept, cholinomimetics may cause bladder outflow obstruction.
Cholinomimetics are believed to have for aricept potential to cause generalized convulsions. Because of see more cholinomimetic another name for aricept 30 mg, cholinesterase inhibitors should be prescribed with care to patients with a history of asthma or obstructive pulmonary disease. The following serious adverse reactions are described below and elsewhere in the labeling: Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials another name for aricept 30 mg another another name for aricept 30 mg and may not reflect the rates observed another name for aricept 30 mg practice.
2018 ©